Previous Article | Next Article ![]()
Journal of Virology, March 1999, p. 2491-2498, Vol. 73, No. 3
Department of Clinical Neurosciences and
Department of Microbiology and Infectious Diseases, University of
Calgary, Calgary, Alberta, Canada T2N 4N1
Received 24 August 1998/Accepted 13 November 1998
Feline immunodeficiency virus (FIV) is a lentivirus causing immune
suppression and neurological disease in cats. Like primate lentiviruses, FIV utilizes the chemokine receptor CXCR4 for infection. In addition, FIV gene expression has been demonstrated in immortalized human cell lines. To investigate the extent and mechanism by which FIV
infected primary and immortalized human cell lines, we compared the
infectivity of two FIV strains, V1CSF and Petaluma, after cell-free infection. FIV genome was detected in infected human peripheral blood mononuclear cells (PBMC) and macrophages at 21 and 14 days postinfection, respectively. Flow cytometry analysis of
FIV-infected human PBMC indicated that antibodies to FIV p24 recognized
12% of the cells. Antibodies binding the CCR3 chemokine receptor
maximally inhibited infection of human PBMC by both FIV strains
compared to antibodies to CXCR4 or CCR5. Reverse transcriptase levels
increased in FIV-infected human PBMC, with detection of viral titers of
101.3 to 102.1 50% tissue culture infective
doses/106 cells depending on the FIV strain examined. Cell
death in human PBMC infected with either FIV strain was significantly
elevated relative to uninfected control cultures. These findings
indicate that FIV can productively infect primary human cell lines and that viral strain specificity should be considered in the development of an FIV vector for gene therapy.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Productive Infection of Human Peripheral Blood
Mononuclear Cells by Feline Immunodeficiency Virus: Implications for
Vector Development
*
Corresponding author. Mailing address: Neurosciences
Research Group, 107-3330 Hospital Dr., Calgary, Alberta, Canada T2N
4N1. Phone: (403) 220-5011. Fax: (403) 283-8731. E-mail:
power{at}ucalgary.ca.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»